Search

everythinglearnresearchcommunity

for

Search:↓

Children with alopecia areata should only get thyroid screening if they have Down syndrome, a family history of thyroid disease, atopy, or signs of thyroid problems.

Dermoscopy can quickly and reliably distinguish Tinea Capitis from Alopecia Areata by identifying specific hair patterns.

Certain factors like patchy hair loss at the back of the head, being female, and younger age at diagnosis can lead to a worse outcome for alopecia areata.

Some vaccines, like the hepatitis B vaccine, might be linked to the hair loss condition Alopecia Areata, but more research is needed.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Men with alopecia areata have different body fat distribution compared to healthy men.

Intralesional triamcinolone is more effective than cryotherapy for treating alopecia areata in middle-aged adults.

The combination of calcipotriol and PRP is the most effective treatment for alopecia areata.

Atopic dermatitis significantly increases the risk of alopecia areata, especially in children.

Alopecia areata significantly increases anxiety, depression, and reduces quality of life.

People with alopecia areata have a higher risk of heart disease.

Alopecia areata in children shows varied symptoms and may involve nails, needing further evaluation for other health issues.

Clobetasol propionate 0.05% ointment is more effective than tacrolimus 0.1% ointment for treating alopecia areata.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

Men with alopecia areata tend to have larger limb and trunk circumferences than healthy men.

Intralesional steroids improve Alopecia Areata, and trichoscopy effectively tracks this improvement.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Mothers with alopecia areata have a higher risk of adverse birth outcomes.

Janus kinase inhibitors effectively treat alopecia areata but may cause relapses and have long-term safety concerns.

Nail changes in alopecia areata are common and may indicate severity and genetic risk.

Alopecia areata might help slow down certain cancers.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

The study suggests that hypothyroidism may cause alopecia areata.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.